[1] |
Ruggiero SL, Mehrotra B, Rosenberg TJ , et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases[J]. J Oral Maxillofac Surg, 2004,62(5):527-534.
doi: 10.1016/j.joms.2004.02.004
URL
|
[2] |
Vahtsevanos K, Kyrgidis A, Verrou E , et al. Longitudinal cohort study of risk factors in cancer patients of bisphos-phonate-related osteonecrosis of the jaw[J]. J Clin Oncol, 2009,27(32):5356-5362.
doi: 10.1200/JCO.2009.21.9584
URL
|
[3] |
范靖雪, 姜礼红, 孟佳 , 等. 双膦酸盐的作用机制和急性时相反应[J]. 中国骨质疏松杂志, 2016,22(9):1216-1220.
|
|
Fan JX, Jiang LH, Meng J , et al. Mechanisms of action and acute phase responses of bisphosphonates[J]. Chin J Osteo-por, 2016,22(9):1216-1220.
|
[4] |
Hughes DE, Wright KR, Uy HL , et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo[J]. J Bone Miner Res, 2009,10(10):1478-1487.
doi: 10.1002/jbmr.5650101008
URL
|
[5] |
Ferretti G, Fabi A, Carlini P , et al. Zoledronic-acid-induced circulating level modifications of angiogenic factors, me-talloproteinases and proinflammatory cytokines in metastatic breast cancer patients[J]. Oncology, 2005,69(1):35-43.
doi: 10.1159/000087286
URL
|
[6] |
Hasmim M, Bieler G, Rüegg C . Zoledronate inhibits endo-thelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways[J]. J Thromb Haemost, 2007,5(1):166-173.
doi: 10.1111/j.1538-7836.2006.02259.x
URL
|
[7] |
Pichardo SEC , Richard van Merkesteyn JP . Bisphosphonate related osteonecrosis of the jaws: spontaneous or dental origin[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013,116(3):287-292.
doi: 10.1016/j.oooo.2013.05.005
URL
|
[8] |
Reid IR, Bolland MJ, Grey AB . Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity[J]. Bone, 2007,41(3):318-320.
doi: 10.1016/j.bone.2007.04.196
URL
|
[9] |
Scheper MA, Badros A, Chaisuparat R , et al. Effect of zole-dronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis[J]. Br J Haematol, 2009,144(5):667-676.
doi: 10.1111/bjh.2009.144.issue-5
URL
|
[10] |
冯驭驰, 赵燕 . 双膦酸盐类药物相关颌骨坏死发病机制及治疗研究进展[J]. 中国骨质疏松杂志, 2014,20(8):998-1002.
|
|
Feng YC, Zhao Y . Research progress of the pathogenesis and treatment of bisphosphonate-related osteonecrosis of the jaws[J]. Chin J Osteopor, 2014,20(8):998-1002.
|
[11] |
赵航 . 双膦酸盐致相关性颌骨坏死的研究进展[J]. 口腔颌面外科杂志, 2013,23(1):72-76.
|
|
Zhao H . Narrative review: bisphosphonate-related osteone-crosis of the jaws[J]. J Oral Maxillofac Surg, 2013,23(1):72-76.
|
[12] |
黄金亮, 唐辉, 徐永清 . 骨髓炎流行病学[J]. 国际骨科学杂志, 2011,32(2):94-95.
|
|
Huang JL, Tang H, Xu YQ . Epidemiology of osteomyelitis[J]. Int J Orthop, 2011,32(2):94-95.
|
[13] |
雷永霞, 梁荣光 . 腕舟骨骨折的影像学表现[J]. 中华关节外科杂志(电子版), 2010,4(2):256-262.
|
|
Lei YX, Liang RG . The imaging features of scaphoid frac-ture[J]. Chin J Joint Surg (Electr Version), 2010,4(2):256-262.
|
[14] |
Somford MP, Draijer FW, Thomassen BJ , et al. Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility[J]. J Bone Miner Rese, 2009,24(10):1736-1740.
doi: 10.1359/jbmr.090408
URL
|
[15] |
于开涛, 邹敬才, 黄红艳 , 等. 双膦酸盐类药物相关性颌骨坏死病例报告及最新进展文献复习[J]. 中国组织工程研究, 2012,16(15):2843-2847.
|
|
Yu KT, Zou JC, Huang HY , et al. Bisphosphonate related osteonecrosis of the jaw: latest progress and case report[J]. J Clin Rehabil Tiss Eng Res, 2012,16(15):2843-2847.
|